Published in Cell Differ on September 01, 1987
Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A (1989) 1.98
Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest (1993) 1.78
Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J (1995) 1.60
Diagnostic biomarkers for oral and periodontal diseases. Dent Clin North Am (2005) 1.56
Effects of short-term and long-term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Dutch CNSLD Study Group. Thorax (1994) 1.26
Increased cellular expression of matrix proteins that regulate mineralization is associated with calcification of native human and porcine xenograft bioprosthetic heart valves. J Clin Invest (1997) 1.16
Endocrine actions of osteocalcin. Int J Endocrinol (2013) 1.02
Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol (1994) 0.98
Recent advances in understanding the mechanisms of osteoclast precursor fusion. J Cell Biochem (2010) 0.93
Age- and gender-related changes in the distribution of osteocalcin in the extracellular matrix of normal male and female bone. Possible involvement of osteocalcin in bone remodeling. J Clin Invest (1994) 0.91
Gene expression pattern during osteogenic differentiation of human periodontal ligament cells in vitro. J Periodontal Implant Sci (2011) 0.86
The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice. Bone (2011) 0.82
An overview of osteocalcin progress. J Bone Miner Metab (2016) 0.81
Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures. J Cell Sci (2015) 0.77
Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg (1982) 12.85
Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev (1994) 4.58
Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol (1990) 4.27
Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone. Physiol Rev (1989) 3.87
Direct identification of the calcium-binding amino acid, gamma-carboxyglutamate, in mineralized tissue. Proc Natl Acad Sci U S A (1975) 3.46
Occult vitamin D deficiency in postmenopausal US women with acute hip fracture. JAMA (1999) 3.14
Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J (1990) 2.55
Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev (1993) 2.52
Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci U S A (2001) 2.52
Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest (1994) 2.42
Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex. J Cell Biochem (1997) 2.27
Congenital vascular lesions: clinical application of a new classification. J Pediatr Surg (1983) 2.20
Expression of an extracellular calcium-sensing receptor in human and mouse bone marrow cells. J Bone Miner Res (1997) 2.11
Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci (2000) 2.08
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc Natl Acad Sci U S A (1997) 2.06
Transcriptional control of osteoblast growth and differentiation. Physiol Rev (1996) 2.06
Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev (2006) 2.04
Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem (2001) 2.01
Application of the biological principle of induced osteogenesis for craniofacial defects. Lancet (1981) 1.92
Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions. Oncogene (2009) 1.87
Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene. J Cell Physiol (2000) 1.76
A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. J Cell Sci (2001) 1.74
Multiple Cbfa/AML sites in the rat osteocalcin promoter are required for basal and vitamin D-responsive transcription and contribute to chromatin organization. Mol Cell Biol (1999) 1.72
Osteocalcin: isolation, characterization, and detection. Methods Enzymol (1984) 1.62
Stage-specific expression of Dlx-5 during osteoblast differentiation: involvement in regulation of osteocalcin gene expression. Mol Endocrinol (1997) 1.61
runt homology domain transcription factors (Runx, Cbfa, and AML) mediate repression of the bone sialoprotein promoter: evidence for promoter context-dependent activity of Cbfa proteins. Mol Cell Biol (2001) 1.59
Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J Cell Biochem (1999) 1.54
Osteoblast-specific gene expression after transplantation of marrow cells: implications for skeletal gene therapy. Proc Natl Acad Sci U S A (1999) 1.53
Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci U S A (1998) 1.52
Cells capable of bone production engraft from whole bone marrow transplants in nonablated mice. J Exp Med (1999) 1.51
Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Dev Biol (1987) 1.51
Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol (1990) 1.50
The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc Natl Acad Sci U S A (1995) 1.49
Osteocalcin gene promoter-binding factors are tissue-specific nuclear matrix components. Proc Natl Acad Sci U S A (1993) 1.46
The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun (1976) 1.38
Replication-dependent histone gene expression is related to Cajal body (CB) association but does not require sustained CB contact. Mol Biol Cell (2001) 1.38
Cell shape and phenotypic expression in chondrocytes. Proc Soc Exp Biol Med (1983) 1.37
Mast cells in hemangiomas and vascular malformations. Pediatrics (1982) 1.37
Tumor cells exhibit deregulation of the cell cycle histone gene promoter factor HiNF-D. Science (1990) 1.37
Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fractures. Osteoporos Int (2008) 1.34
Differential regulation of the two principal Runx2/Cbfa1 n-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype. Endocrinology (2001) 1.34
Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry (1993) 1.33
Carboxylated calcium-binding proteins and vitamin K. N Engl J Med (1980) 1.31
Vitamin D-mediated modifications in protein-DNA interactions at two promoter elements of the osteocalcin gene. Proc Natl Acad Sci U S A (1990) 1.30
Classification of pediatric vascular lesions. Plast Reconstr Surg (1982) 1.30
Human H4 histone gene transcription requires the proliferation-specific nuclear factor HiNF-D. Auxiliary roles for HiNF-C (Sp1-like) and HiNF-A (high mobility group-like). J Biol Chem (1989) 1.28
Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation. Endocrinology (1996) 1.28
Apoptosis during bone-like tissue development in vitro. J Cell Biochem (1998) 1.25
The presence of protein-bound gamma-carboxyglutamic acid in calcium-containing renal calculi. J Clin Invest (1977) 1.24
The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor. Proc Natl Acad Sci U S A (1999) 1.24
Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2. J Biol Chem (1999) 1.22
Engraftment of a clonal bone marrow stromal cell line in vivo stimulates hematopoietic recovery from total body irradiation. Proc Natl Acad Sci U S A (1987) 1.21
An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci U S A (1996) 1.21
Transcriptional control of the tissue-specific, developmentally regulated osteocalcin gene requires a binding motif for the Msx family of homeodomain proteins. Proc Natl Acad Sci U S A (1994) 1.20
The physiologic significance of plasma transport of vitamin D and metabolites. Am J Med (1974) 1.20
Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. J Cell Biochem (1998) 1.19
TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol (1994) 1.17
Sequence-specific DNA-binding proteins are components of a nuclear matrix-attachment site. Proc Natl Acad Sci U S A (1992) 1.16
The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts. Cancer Res (1999) 1.13
Overlapping and CpG methylation-sensitive protein-DNA interactions at the histone H4 transcriptional cell cycle domain: distinctions between two human H4 gene promoters. Mol Cell Biol (1992) 1.12
Atherocalcin, a gamma-carboxyglutamic acid containing protein from atherosclerotic plaque. Biochem Biophys Res Commun (1979) 1.12
Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem (1992) 1.11
Progressive changes in the protein composition of the nuclear matrix during rat osteoblast differentiation. Proc Natl Acad Sci U S A (1990) 1.11
Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts. J Cell Biochem (2001) 1.10
Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem (1992) 1.10
Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Mol Endocrinol (1996) 1.09
Association of congenital deficiency of multiple vitamin K-dependent coagulation factors and the phenotype of the warfarin embryopathy: clues to the mechanism of teratogenicity of coumarin derivatives. Am J Hum Genet (1987) 1.08
Intranuclear trafficking of transcription factors: implications for biological control. J Cell Sci (2000) 1.08
Nuclear structure-gene expression interrelationships: implications for aberrant gene expression in cancer. Cancer Res (2000) 1.08
Induced osteogenesis for repair and construction in the craniofacial region. Plast Reconstr Surg (1980) 1.07
In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status. J Clin Endocrinol Metab (1998) 1.06
Modifications of protein-DNA interactions in the proximal promoter of a cell-growth-regulated histone gene during onset and progression of osteoblast differentiation. Proc Natl Acad Sci U S A (1990) 1.05
Regulation of histone gene expression. Curr Opin Cell Biol (1992) 1.05
Fate of mineralized and demineralized osseous implants in cranial defects. Calcif Tissue Int (1981) 1.05
Effects of latency and rate on bone formation in a porcine mandibular distraction model. J Oral Maxillofac Surg (2000) 1.04
Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab (1984) 1.03
Effects of medium perfusion on matrix production by bovine chondrocytes in three-dimensional collagen sponges. J Biomed Mater Res (2001) 1.03
Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. J Cell Biochem (1991) 1.01
Transcriptional control of cell cycle progression: the histone gene is a paradigm for the G1/S phase and proliferation/differentiation transitions. Cell Biol Int (1996) 1.01
A human histone H2B.1 variant gene, located on chromosome 1, utilizes alternative 3' end processing. J Cell Biochem (1992) 1.01
Influence of estrogen status on endosseous implant osseointegration. J Oral Maxillofac Surg (2001) 1.01
Correlation of plain radiographic indices of the hip with quantitative bone mineral density. Osteoporos Int (2007) 1.01
Transcription of histone H4, H3, and H1 cell cycle genes: promoter factor HiNF-D contains CDC2, cyclin A, and an RB-related protein. Proc Natl Acad Sci U S A (1994) 1.00
The roles of revascularization and resorption on endurance of craniofacial onlay bone grafts in the rabbit. Plast Reconstr Surg (1994) 1.00
Fractures in the elderly and vitamin D. J Nutr Health Aging (2002) 1.00
Three-dimensional composite of demineralized bone powder and collagen for in vitro analysis of chondroinduction of human dermal fibroblasts. Biomaterials (1996) 1.00
Cell cycle controlled histone H1, H3, and H4 genes share unusual arrangements of recognition motifs for HiNF-D supporting a coordinate promoter binding mechanism. J Cell Physiol (1994) 1.00
Polyethylene glycol/microfibrillar collagen composite as a new resorbable hemostatic bone wax. J Biomed Mater Res (1998) 0.99
Cell cycle independent interaction of CDC2 with the centrosome, which is associated with the nuclear matrix-intermediate filament scaffold. Proc Natl Acad Sci U S A (1997) 0.99
Multinucleated cells in pigmented villonodular synovitis and giant cell tumor of tendon sheath express features of osteoclasts. Am J Pathol (1997) 0.99
Pseudo-tumoural presentation of certain cases of subacute sclerosing leucoencephalitis. J Neurol Sci (1967) 0.99
Histone gene transcription: a model for responsiveness to an integrated series of regulatory signals mediating cell cycle control and proliferation/differentiation interrelationships. J Cell Biochem (1994) 0.98
Activity of the osteocalcin promoter in skeletal sites of transgenic mice and during osteoblast differentiation in bone marrow-derived stromal cell cultures: effects of age and sex. Endocrinology (1997) 0.97
The CCAAT displacement protein/cut homeodomain protein represses osteocalcin gene transcription and forms complexes with the retinoblastoma protein-related protein p107 and cyclin A. Cancer Res (1999) 0.97
The vitamin K-dependent synthesis of gamma-carboxyglutamic acid by bone microsomes. J Biol Chem (1978) 0.97
In vivo occupancy of the vitamin D responsive element in the osteocalcin gene supports vitamin D-dependent transcriptional upregulation in intact cells. Proc Natl Acad Sci U S A (1994) 0.97
Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease. J Clin Endocrinol Metab (1983) 0.97